CanSino Biologics Inc. (688185.SS)

CNY 63.42

(0.21%)

Operating Income Summary of CanSino Biologics Inc.

  • CanSino Biologics Inc.'s latest annual operating income in 2023 was -1.93 Billion CNY , down -31.91% from previous year.
  • CanSino Biologics Inc.'s latest quarterly operating income in 2024 Q3 was 6.6 Million CNY , up 109.05% from previous quarter.
  • CanSino Biologics Inc. reported an annual operating income of -1.36 Billion CNY in 2022, down -171.6% from previous year.
  • CanSino Biologics Inc. reported an annual operating income of 1.91 Billion CNY in 2021, up 534.14% from previous year.
  • CanSino Biologics Inc. reported a quarterly operating income of -72.94 Million CNY for 2024 Q2, up 43.62% from previous quarter.
  • CanSino Biologics Inc. reported a quarterly operating income of 6.6 Million CNY for 2024 Q3, up 109.05% from previous quarter.

Annual Operating Income Chart of CanSino Biologics Inc. (2023 - 2016)

Historical Annual Operating Income of CanSino Biologics Inc. (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -1.93 Billion CNY -31.91%
2022 -1.36 Billion CNY -171.6%
2021 1.91 Billion CNY 534.14%
2020 -440.32 Million CNY -117.9%
2019 -202.07 Million CNY -45.82%
2018 -138.57 Million CNY -117.22%
2017 -63.79 Million CNY -21.09%
2016 -52.68 Million CNY 0.0%

Peer Operating Income Comparison of CanSino Biologics Inc.

Name Operating Income Operating Income Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.25 Billion CNY 159.435%
Yabao Pharmaceutical Group Co., Ltd 226.33 Million CNY 955.575%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 5.12 Billion CNY 137.815%
Harbin Pharmaceutical Group Co., Ltd. 659.62 Million CNY 393.569%
Tasly Pharmaceutical Group Co., Ltd 1.22 Billion CNY 257.708%
Zhejiang Medicine Co., Ltd. 380.15 Million CNY 609.384%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.09 Billion CNY 276.528%
Lionco Pharmaceutical Group Co.,Ltd. -148.98 Million CNY -1199.81%
Humanwell Healthcare (Group) Co.,Ltd. 3.44 Billion CNY 156.175%
Ginwa Enterprise (Group) Inc. -1.69 Million CNY -114148.069%
Joincare Pharmaceutical Group Industry Co.,Ltd. 3.5 Billion CNY 155.224%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 22.03 Million CNY 8886.676%
China Animal Husbandry Industry Co., Ltd. 402.76 Million CNY 580.789%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 249.11 Million CNY 877.339%
Zhejiang Huahai Pharmaceutical Co., Ltd. 1.36 Billion CNY 242.106%
Shanghai Haoyuan Chemexpress Co., Ltd. 128.32 Million CNY 1608.99%
Ningbo Menovo Pharmaceutical Co., Ltd. 18.74 Million CNY 10428.935%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.17 Billion CNY 264.697%
Chongqing Taiji Industry(Group) Co.,Ltd 1.17 Billion CNY 265.07%
HPGC Renmintongtai Pharmaceutical Corporation 411.84 Million CNY 570.194%
Nanjing Well Pharmaceutical Group Co.,Ltd. 121.77 Million CNY 1690.18%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 169.4 Million CNY 1243.084%
Henan Lingrui Pharmaceutical Co., Ltd. 656.3 Million CNY 395.055%
Shenzhen Chipscreen Biosciences Co., Ltd. 97.07 Million CNY 2094.881%
Guizhou Yibai Pharmaceutical Co., Ltd. 145.51 Million CNY 1430.789%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 563.79 Million CNY 443.471%
Zhongzhu Healthcare Holding Co.,Ltd -135.23 Million CNY -1331.91%
Beijing Tongrentang Co., Ltd 3.08 Billion CNY 162.787%
KPC Pharmaceuticals, Inc. 568.49 Million CNY 440.63%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 97.08 Million CNY 2094.513%
North China Pharmaceutical Company Ltd. 540.51 Million CNY 458.264%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.51 Billion CNY 227.817%
Tibet Weixinkang Medicine Co., Ltd. 174.96 Million CNY 1206.784%
China National Medicines Corporation Ltd. 2.94 Billion CNY 165.769%
Zhejiang Hisun Pharmaceutical Co., Ltd. 89.44 Million CNY 2265.029%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 473.24 Million CNY 509.19%
ChengDu ShengNuo Biotec Co.,Ltd. 81.1 Million CNY 2487.719%
Dali Pharmaceuticalco.,Ltd -17.03 Million CNY -11267.407%
Changchun BCHT Biotechnology Co. 559.29 Million CNY 446.236%
Zhejiang Shengda Bio-Pharm Co., Ltd. -45.67 Million CNY -4139.572%
Shanghai Jiaoda Onlly Co.,Ltd -25.57 Million CNY -7471.651%
Jiang Zhong Pharmaceutical Co.,Ltd 894.11 Million CNY 316.579%
Mayinglong Pharmaceutical Group Co., LTD. 536.62 Million CNY 460.858%
Cisen Pharmaceutical Co., Ltd. 592.57 Million CNY 426.787%
Hunan Warrant Pharmaceutical Co.,Ltd 237.11 Million CNY 916.678%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 3.3 Billion CNY 158.548%
Jianmin Pharmaceutical Group Co.,Ltd. 573.86 Million CNY 437.446%
Hunan Fangsheng Pharmaceutical Co., Ltd. 196.44 Million CNY 1085.752%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 132.68 Million CNY 1559.44%
Guobang Pharma Ltd. 702.26 Million CNY 375.746%
Shaanxi Kanghui Pharmaceutical Co., Ltd. -61.8 Million CNY -3033.31%
Kangmei Pharmaceutical Co., Ltd. 86.66 Million CNY 2334.394%
Shandong Buchang Pharmaceuticals Co., Ltd. 436.01 Million CNY 544.124%
Zhejiang Starry Pharmaceutical Co.,Ltd. 138.93 Million CNY 1493.798%
Henan Taloph Pharmaceutical Stock Co.,Ltd 44.16 Million CNY 4484.466%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 461.93 Million CNY 519.203%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -331.9 Million CNY -483.434%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 194.16 Million CNY 1097.349%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.08 Billion CNY 279.033%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.45 Million CNY 1090.755%
Tibet Rhodiola Pharmaceutical Holding Co. 899.09 Million CNY 315.38%
Sichuan Huiyu Pharmaceutical Co., Ltd. 124.36 Million CNY 1657.039%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 173.9 Million CNY 1213.492%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 174.77 Million CNY 1207.996%
Shandong Lukang Pharmaceutical Co.,Ltd. 277.16 Million CNY 798.659%